PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company Pharmaceutical Investing
TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 Pharmaceutical Investing
Genocea Biosciences, Inc. Announces Pricing of $55 Million Concurrent Public Offerings Biotech Investing
Strongbridge Biopharma Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris Biotech Investing
Caladrius Biosciences Announces Completion of Enrollment of Phase 2 T-Rex Clinical Trial of CLBS03 for Type 1 Diabetes Pharmaceutical Investing
